Beam Therapeutics Inc. (NASDAQ:BEAM) IPO
IPO
Priced at US$17.00 a share on Feb 5, 2020.
- Price
- US$17.00 a share
- Shares offered
- 10,588,236 shares of common stock
- Offering size
- US$180 million
- Underwriters' option
- Up to 1,588,235 more shares
- Listing
- BEAM on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Jefferies, Barclays, Wedbush PacGrow · In the order on the cover
- Shares delivered
- On or about Feb 10, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 29, 2019 |
| Filed publicly | Sep 27, 2019 |
| Amended 4 times | Newest Feb 5, 2020 |
| Shares registered with an exchange | Jan 31, 2020 |
| Declared effective by the SEC | Feb 5, 2020 |
| Final prospectus, with the price | Feb 7, 2020 |
Filings
From the cover of the final prospectus (424B4) filed Feb 7, 2020